ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
ROBINS-I: инструмент для оценки риска смещения в нерендомизированных исследованиях вмешательств
2016-10-12
SCID: 54.1/ssqkz7v8
Discuss with AI
ROBINS-Icomparative effectivenessnon-randomised studies of interventionsrisk of biassystematic reviews
Figures from the paper
Abstract (AI)
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
Key Findings
1
ROBINS-I is a newly developed tool for assessing risk of bias in non-randomised studies of interventions.
2
ROBINS-I is intended to help users appraise strengths and weaknesses of non-randomised intervention studies.
3
The tool evaluates bias in estimates of comparative effectiveness (harm or benefit) from studies without randomised allocation.
4
The tool is particularly useful for conducting systematic reviews that include non-randomised studies.
Research Object
Non-randomised studies of interventions (studies that did not use randomisation to allocate individuals or clusters to comparison groups)
Research Subject
Risk of bias in estimates of comparative effectiveness (harm or benefit) of interventions and systematic appraisal using the ROBINS-I assessment tool
Publication Details
Publication Date
2016-10-12
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by6
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management2024
The role of agentic artificial intelligence in healthcare: a scoping review2026
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis2025
A systematic review and three-level meta-analysis of the effects of stroboscopic training on sport-specific performance2025
Outpatient Treatment of Low‐risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review2020
RoB 2: a revised tool for assessing risk of bias in randomised trials2019